Filed: 8/14/2026ACC: 0000908834-26-000432
📋 What this filing means
FARALLON CAPITAL MANAGEMENT, L.L.C. filed this quarterly 13F‑HR report disclosing 89 equity positions with a total reported market value of $21.68B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
89
Positions
$21.68B
Total AUM (reported)
365.18M
Total Shares
Allocation by class
COM$14.55B67.1%
TR UNIT$4.48B20.7%
COM NEW$770.34M3.6%
SHS$506.40M2.3%
SHS CL A$458.58M2.1%
SPON ADR REP A$137.58M0.6%
ADR$125.55M0.6%
Portfolio Concentration
Top 3$8.64B39.9%
4–10$4.83B22.3%
11–25$5.89B27.2%
Rest$2.32B10.7%
Top 3 weight
39.9%
Top 10 weight
62.1%
Voting Authority Distribution
Total shares with voting rights: 365.18M
Sole
Full voting authority
365.18M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other89
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings89
Rows:
STATE STR SPDR S&P 500 ETF T
OTRShares6M
TypeSH
Market value$4.48B
20.67%
Sole
6M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
OTRShares13.55M
TypeSH
Market value$2.54B
11.71%
Sole
13.55M
Shared
0.00
None
0.00
ELECTRONIC ARTS INC
OTRShares7.92M
TypeSH
Market value$1.62B
7.49%
Sole
7.92M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
OTRShares10.74M
TypeSH
Market value$800.14M
3.69%
Sole
10.74M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
OTRShares6.35M
TypeSH
Market value$778.25M
3.59%
Sole
6.35M
Shared
0.00
None
0.00
EXELIXIS INC
OTRShares13.47M
TypeSH
Market value$732.79M
3.38%
Sole
13.47M
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
OTRShares8.37M
TypeSH
Market value$666.94M
3.08%
Sole
8.37M
Shared
0.00
None
0.00
AMAZON COM INC
OTRShares2.63M
TypeSH
Market value$627.55M
2.90%
Sole
2.63M
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
OTRShares5.58M
TypeSH
Market value$619.43M
2.86%
Sole
5.58M
Shared
0.00
None
0.00
NATERA INC
OTRShares2.22M
TypeSH
Market value$602.18M
2.78%
Sole
2.22M
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
OTRShares1.27M
TypeSH
Market value$528.07M
2.44%
Sole
1.27M
Shared
0.00
None
0.00
THERMO FISHER SCIENTIFIC INC
OTRShares1.05M
TypeSH
Market value$526.02M
2.43%
Sole
1.05M
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
OTRShares14.31M
TypeSH
Market value$506.40M
2.34%
Sole
14.31M
Shared
0.00
None
0.00
AON PLC
OTRShares1.38M
TypeSH
Market value$458.58M
2.12%
Sole
1.38M
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
OTRShares10.52M
TypeSH
Market value$449.04M
2.07%
Sole
10.52M
Shared
0.00
None
0.00
BROADCOM INC
OTRShares1.15M
TypeSH
Market value$435.09M
2.01%
Sole
1.15M
Shared
0.00
None
0.00
MICROSOFT CORP
OTRShares1.11M
TypeSH
Market value$415.12M
1.92%
Sole
1.11M
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
OTRShares12.28M
TypeSH
Market value$383.78M
1.77%
Sole
12.28M
Shared
0.00
None
0.00
KKR & CO INC
OTRShares4.12M
TypeSH
Market value$377.98M
1.74%
Sole
4.12M
Shared
0.00
None
0.00
SYNOPSYS INC
OTRShares829.60K
TypeSH
Market value$370.06M
1.71%
Sole
829.60K
Shared
0.00
None
0.00
BEAM THERAPEUTICS INC
OTRShares10.24M
TypeSH
Market value$351.31M
1.62%
Sole
10.24M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
OTRShares8.99M
TypeSH
Market value$336.37M
1.55%
Sole
8.99M
Shared
0.00
None
0.00
GRAIL INC
OTRShares4.16M
TypeSH
Market value$284.11M
1.31%
Sole
4.16M
Shared
0.00
None
0.00
WABTEC
OTRShares894.50K
TypeSH
Market value$241.16M
1.11%
Sole
894.50K
Shared
0.00
None
0.00
IMMUNOVANT INC
OTRShares5.80M
TypeSH
Market value$223.67M
1.03%
Sole
5.80M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
STATE STR SPDR S&P 500 ETF TOTR | TR UNIT | 6M | SH | $4.48B 20.67% | 6M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCOTR | COM | 13.55M | SH | $2.54B 11.71% | 13.55M | 0.00 | 0.00 |
ELECTRONIC ARTS INCOTR | COM | 7.92M | SH | $1.62B 7.49% | 7.92M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCOTR | COM | 10.74M | SH | $800.14M 3.69% | 10.74M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCOTR | COM | 6.35M | SH | $778.25M 3.59% | 6.35M | 0.00 | 0.00 |
EXELIXIS INCOTR | COM | 13.47M | SH | $732.79M 3.38% | 13.47M | 0.00 | 0.00 |
LIQUIDIA CORPORATIONOTR | COM NEW | 8.37M | SH | $666.94M 3.08% | 8.37M | 0.00 | 0.00 |
AMAZON COM INCOTR | COM | 2.63M | SH | $627.55M 2.90% | 2.63M | 0.00 | 0.00 |
LANTHEUS HLDGS INCOTR | COM | 5.58M | SH | $619.43M 2.86% | 5.58M | 0.00 | 0.00 |
NATERA INCOTR | COM | 2.22M | SH | $602.18M 2.78% | 2.22M | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCOTR | COM | 1.27M | SH | $528.07M 2.44% | 1.27M | 0.00 | 0.00 |
THERMO FISHER SCIENTIFIC INCOTR | COM | 1.05M | SH | $526.02M 2.43% | 1.05M | 0.00 | 0.00 |
ROIVANT SCIENCES LTDOTR | SHS | 14.31M | SH | $506.40M 2.34% | 14.31M | 0.00 | 0.00 |
AON PLCOTR | SHS CL A | 1.38M | SH | $458.58M 2.12% | 1.38M | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPOTR | COM | 10.52M | SH | $449.04M 2.07% | 10.52M | 0.00 | 0.00 |
BROADCOM INCOTR | COM | 1.15M | SH | $435.09M 2.01% | 1.15M | 0.00 | 0.00 |
MICROSOFT CORPOTR | COM | 1.11M | SH | $415.12M 1.92% | 1.11M | 0.00 | 0.00 |
TANGO THERAPEUTICS INCOTR | COM | 12.28M | SH | $383.78M 1.77% | 12.28M | 0.00 | 0.00 |
KKR & CO INCOTR | COM | 4.12M | SH | $377.98M 1.74% | 4.12M | 0.00 | 0.00 |
SYNOPSYS INCOTR | COM | 829.60K | SH | $370.06M 1.71% | 829.60K | 0.00 | 0.00 |
BEAM THERAPEUTICS INCOTR | COM | 10.24M | SH | $351.31M 1.62% | 10.24M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INOTR | COM | 8.99M | SH | $336.37M 1.55% | 8.99M | 0.00 | 0.00 |
GRAIL INCOTR | COM | 4.16M | SH | $284.11M 1.31% | 4.16M | 0.00 | 0.00 |
WABTECOTR | COM | 894.50K | SH | $241.16M 1.11% | 894.50K | 0.00 | 0.00 |
IMMUNOVANT INCOTR | COM | 5.80M | SH | $223.67M 1.03% | 5.80M | 0.00 | 0.00 |
Page 1 of 4